- Home
- HURA vs GMGI Comparison
HURA vs GMGI Comparison
Compare HURA & GMGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- GMGI
- Stock Information
- Founded
- HURA 2009
- GMGI 2008
- Country
- HURA United States
- GMGI United States
- Employees
- HURA N/A
- GMGI N/A
- Industry
- HURA
- GMGI Computer Software: Prepackaged Software
- Sector
- HURA
- GMGI Technology
- Exchange
- HURA Nasdaq
- GMGI Nasdaq
- Market Cap
- HURA 126.1M
- GMGI 142.5M
- IPO Year
- HURA N/A
- GMGI N/A
- Fundamental
- Price
- HURA $2.59
- GMGI $1.03
- Analyst Decision
- HURA Strong Buy
- GMGI Strong Buy
- Analyst Count
- HURA 2
- GMGI 1
- Target Price
- HURA $11.50
- GMGI $4.00
- AVG Volume (30 Days)
- HURA 214.3K
- GMGI 242.1K
- Earning Date
- HURA 11-13-2025
- GMGI 11-12-2025
- Dividend Yield
- HURA N/A
- GMGI N/A
- EPS Growth
- HURA N/A
- GMGI N/A
- EPS
- HURA N/A
- GMGI N/A
- Revenue
- HURA N/A
- GMGI $172,818,124.00
- Revenue This Year
- HURA N/A
- GMGI $25.43
- Revenue Next Year
- HURA N/A
- GMGI $13.00
- P/E Ratio
- HURA N/A
- GMGI N/A
- Revenue Growth
- HURA N/A
- GMGI 54.66
- 52 Week Low
- HURA $1.80
- GMGI $0.91
- 52 Week High
- HURA $8.40
- GMGI $3.06
- Technical
- Relative Strength Index (RSI)
- HURA 45.68
- GMGI 39.07
- Support Level
- HURA $2.38
- GMGI $1.02
- Resistance Level
- HURA $2.66
- GMGI $1.16
- Average True Range (ATR)
- HURA 0.12
- GMGI 0.08
- MACD
- HURA 0.01
- GMGI 0.01
- Stochastic Oscillator
- HURA 42.86
- GMGI 22.19
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About GMGI Golden Matrix Group Inc.
Golden Matrix Group Inc is an established gaming technology company. The company develops and owns online gaming IP and builds configurable and scalable white-label social gaming platforms for its international customers. The company operates in three reportable segments; MeridianBet Group, GMAG, RKings & CFAC. The MeridianBet Group segment earns majority revenue. The company operates in UK, Europe, Asia Pacific, Central and South America, Australia and Africa. It offers configurable and scalable iGaming platforms and operate some of the industry's iconic brands, including MexPlay, GM-AG, and others.